secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-06-18T21:15:27+00:00
Accession:  0001213900-26-070212
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma regains compliance with Nasdaq minimum bid price rule
-----------------------------------------------------------------

- Received Nasdaq confirmation on June 17, 2026, that it regained compliance with Listing Rule 5550(a)(2).
- Closing bid price was $1.00 or greater from June 3 to June 16, 2026, satisfying the requirement.
- Nasdaq considers the matter closed; SILO continues trading on the Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026070212/0001213900-26-070212-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026070212/ea0295339-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-070212

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer